|
|
Volumn 361, Issue 1, 2009, Pages 93-
|
|
Rosuvastatin in patients undergoing hemodialysis [7]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ROSUVASTATIN;
FLUOROBENZENE;
PYRIMIDINE DERIVATIVE;
SULFONAMIDE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHRONIC KIDNEY DISEASE;
DIABETES MELLITUS;
DIABETIC NEPHROPATHY;
HEART PROTECTION;
HEMODIALYSIS PATIENT;
HUMAN;
LETTER;
MORTALITY;
PRIORITY JOURNAL;
CHRONIC KIDNEY FAILURE;
NOTE;
RENAL REPLACEMENT THERAPY;
RISK FACTOR;
CARDIOVASCULAR DISEASES;
DIABETES COMPLICATIONS;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
KIDNEY FAILURE, CHRONIC;
PYRIMIDINES;
RENAL DIALYSIS;
RISK FACTORS;
SULFONAMIDES;
|
|
EID: 67649644922
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc090901 Document Type: Letter |
|
Times cited : (6)
|
|
References (4)
|
